BioNTech, BMS Partner to Advance BNT327 in Solid Tumor Cancers

An agreement has been reached between BioNTech and Bristol Myers Squibb for the worldwide co-development and co-commercialization of BioNTech's investigational bispecific antibody BNT327 across a variety of solid tumor types.

NPPA Regulates 41 Drug Combinations to Curb Healthcare Costs

The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price ceilings on 41 combinations of drugs, including 18 types of Boehringer Ingelheim's

ASPA marks World Anti-Counterfeiting Day with major industry initiative

The Authentication Solution Providers’ Association (ASPA) ahead of World Anti-Counterfeiting Day, has commissioned the second edition of its flagship industry report, ‘State of Counterfeiting in India – 2025

Allarity Begins Phase 2 Trial of Stenoparib in Advanced Ovarian Cancer

Allarity Therapeutics, a Phase 2-stage biopharmaceutical with activities in Copenhagen and Boston, has formally enrolled its first patient in its newly launched Phase 2 trial

New Treatment Aumolertinib Approved for EGFR-Positive NSCLC

Aumolertinib (Aumseqa) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) for adult patients with non-small cell lung cancer (NSCLC).

Gland Pharma Received Approval from USFDA for its Blood Pressure Drug

Gland Pharma Limited saw its shares rise nearly 3% during intraday trading on Wednesday following the announcement of a major regulatory accomplishment...

Reckitt & PHFI Unite to Power Next-Gen Public Health Initiatives

Reckitt, the world's leading consumer health and hygiene company, associated with the Public Health Foundation of India

Ayush Exports Gets a Boost as Ayushexcil Joins Official Certifying Agencies

A step in the direction of streamlining and simplification of the export procedure for India's traditional medicinal industry, the Ministry of Commerce and Industry

India to Boost its PLI Initiative for Drug Manufacturing

India is about to give a significant boost to its production-linked incentive (PLI) scheme for pharmaceuticals as it seeks to establish a stronger domestic production of key starting materials (KSMs)...

Zydus to acquire US biotech firm Agenus in Emeryville and Berkeley

Zydus Lifesciences is entering the global biologics contract development and manufacturing (CDMO) arena with its acquisition of two biologics facilities from Agenus at Emeryville and Berkeley in California...

© 2025 India Pharma Outlook. All Rights Reserved.